Search results
Results from the WOW.Com Content Network
This article lists veterinary pharmaceutical drugs alphabetically by name. Many veterinary drugs have more than one name and, therefore, the same drug may be listed more than once. Abbreviations are used in the list as follows: INN = International Nonproprietary Name; BAN = British Approved Name; USAN = United States Adopted Name
Maropitant (INN; [3] brand name: Cerenia, used as maropitant citrate , is a neurokinin-1 (NK 1) receptor antagonist developed by Zoetis specifically for the treatment of motion sickness and vomiting in dogs. It was approved by the FDA in 2007, for use in dogs [4] [5] and in 2012, for cats. [6]
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
The Prescribing Information follows one of two formats: "physician labeling rule" format or "old" (non-PLR) format. For "old" format labeling a "product title" may be listed first and may include the proprietary name (if any), the nonproprietary name, dosage form(s), and other information about the product. The other sections are as follows:
This drug was approved for sale after only 135 dogs received the injection (2). Since that time, more than 21 million doses of Librela have been given. The company reports that only 0.2% of dogs ...
Postpartum infections, also known as childbed fever and puerperal fever, are any bacterial infections of the female reproductive tract following childbirth or miscarriage. [1] Signs and symptoms usually include a fever greater than 38.0 °C (100.4 °F), chills, lower abdominal pain, and possibly bad-smelling vaginal discharge . [ 1 ]
Female dogs are at risk for endometritis and pyometra in the postpartum period and after estrus or vaginitis. Signs and symptoms include fever, lethargy, loss of appetite, excessive thirst, restlessness, a foul smelling vaginal discharge which may or may not be bloody, infertility, or they may be asymptomatic.
This analgesic and anti-inflammatory drug is primarily used as a pain relief for mild to moderate inflammation related to osteoarthritis in dogs. Grapiprant has been approved by the FDA's Center for Veterinary Medicine and was categorized as a non- cyclooxygenase inhibiting non-steroidal anti-inflammatory drug (NSAID) in March 2016.